{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:08:50Z","timestamp":1792786130506,"version":"4.5.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC1809"],"award-info":[{"award-number":["2026NSFSC1809"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Research Fund of West China Hospital"},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["HXBH042"],"award-info":[{"award-number":["HXBH042"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Project of Science & Technology Department of Sichuan Province","award":["2024YFFK0041"],"award-info":[{"award-number":["2024YFFK0041"]}],"id":[{"id":"https:\/\/ror.org\/04323m874","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Science and Technology Projects of Xizang Autonomous Region","award":["XZ202601ZY0113"],"award-info":[{"award-number":["XZ202601ZY0113"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Rapid symptom control may facilitate earlier mobility and self-management in symptomatic knee OA (KOA), but evidence for combining oral and topical NSAIDs remains limited. This study aimed to determine whether adding a topical flurbiprofen patch to oral celecoxib provides greater short-term improvements in pain, physical function, quality of life and patient global assessment (PGA) than oral celecoxib alone in patients with symptomatic KOA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this open-label randomized controlled trial conducted at a tertiary academic hospital from January 2024 to March 2025, 90 patients with chronic inflammatory symptomatic KOA were randomized 1:1 to receive either oral celecoxib 200\u2009mg once daily or celecoxib plus topical flurbiprofen patch twice daily. Outcomes were assessed at baseline and on days 3, 7 and 14. Primary outcomes were pain severity by visual analogue scale (VAS) and functional impairment by WOMAC. Secondary outcomes included quality of life by SF-36 and PGA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-nine patients completed the study (45 celecoxib; 44 combination therapy). Baseline characteristics were comparable between the groups. Compared with celecoxib alone, combination therapy produced greater early pain relief, with larger VAS reductions on day 3 (3.4\u2009\u00b1\u20090.9 vs 2.0\u2009\u00b1\u20090.8, P\u2009&amp;lt;\u20090.01) and day 7 (3.9\u2009\u00b1\u20091.0 vs 3.3\u2009\u00b1\u20091.0, P\u2009=\u20090.02), but not day 14. WOMAC improvement was greater in the combination group on days 3, 7 and 14 (all P\u2009&amp;lt;\u20090.01). At day 14, SF-36 health domain scores and PGA ratings were also higher with combination therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adding topical flurbiprofen patch to oral celecoxib provided faster early improvement in pain and function and better short-term patient-reported outcomes in symptomatic KOA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Registry: ChiCTR1800014584.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keag488","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:48:46Z","timestamp":1788954526000},"source":"Crossref","is-referenced-by-count":0,"title":["Celecoxib plus topical flurbiprofen patch versus celecoxib alone for symptomatic knee OA: a randomized controlled trial"],"prefix":"10.1093","volume":"65","author":[{"given":"Kaibo","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, and Orthopedic Research Institution, West China Hospital of Sichuan University , Chengdu, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Knee Preservation Center, Ya\u2019an People\u2019s Hospital , Yaan, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Knee Preservation Center, Ya\u2019an People\u2019s Hospital , Yaan, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangtao","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Knee Preservation Center, Ya\u2019an People\u2019s Hospital , Yaan, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of GCP Center, Ya\u2019an People\u2019s Hospital , Yaan, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of GCP Center, Ya\u2019an People\u2019s Hospital , Yaan, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinsheng","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, and Orthopedic Research Institution, West China Hospital of Sichuan University , Chengdu, Sichuan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"2026092513474583500_keag488-B1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.arr.2017.07.004","article-title":"Aging and osteoarthritis: central role of the extracellular matrix","volume":"40","author":"Rahmati","year":"2017","journal-title":"Ageing Res Rev"},{"key":"2026092513474583500_keag488-B2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","article-title":"Osteoarthritis","volume":"405","author":"Kloppenburg","year":"2025","journal-title":"Lancet"},{"key":"2026092513474583500_keag488-B3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the Global Burden of Disease Study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026092513474583500_keag488-B4","doi-asserted-by":"crossref","first-page":"100587","DOI":"10.1016\/j.eclinm.2020.100587","article-title":"Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies","volume":"29\u201330","author":"Cui","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2026092513474583500_keag488-B5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.semarthrit.2019.04.008","article-title":"An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)","volume":"49","author":"Bruy\u00e8re","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2026092513474583500_keag488-B6","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1001\/jama.2024.17482","article-title":"What is knee osteoarthritis?","volume":"332","author":"Voelker","year":"2024","journal-title":"JAMA"},{"key":"2026092513474583500_keag488-B7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41584-020-00523-9","article-title":"Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines","volume":"17","author":"Arden","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2026092513474583500_keag488-B8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40265-025-02162-4","article-title":"Safety of anti-osteoarthritis medications: a systematic literature review of post-marketing surveillance studies","volume":"85","author":"Honvo","year":"2025","journal-title":"Drugs"},{"key":"2026092513474583500_keag488-B9","first-page":"Cd009865","article-title":"Celecoxib for osteoarthritis","volume":"5","author":"Puljak","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026092513474583500_keag488-B10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.joca.2021.06.004","article-title":"Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data","volume":"29","author":"Zeng","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"2026092513474583500_keag488-B11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.joca.2022.11.005","article-title":"Pharmaceutical treatment of osteoarthritis","volume":"31","author":"Richard","year":"2023","journal-title":"Osteoarthritis Cartilage"},{"key":"2026092513474583500_keag488-B12","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1097\/CM9.0000000000002797","article-title":"Efficacy and safety of flurbiprofen cataplasms versus loxoprofen sodium cataplasms in knee osteoarthritis: a randomized controlled trial","volume":"136","author":"Li","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"2026092513474583500_keag488-B13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/JPR.S131779","article-title":"The efficacy and safety of S-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase II, randomized, double-blind, placebo-controlled, dose-finding study","volume":"10","author":"Yataba","year":"2017","journal-title":"J Pain Res"},{"key":"2026092513474583500_keag488-B14","doi-asserted-by":"crossref","first-page":"e70140","DOI":"10.1002\/ejp.70140","article-title":"Multifactorial machine learning algorithm integration of pain mechanisms can predict the efficacy of 3-week NSAID plus paracetamol in patients with painful knee osteoarthritis","volume":"29","author":"Giordano","year":"2025","journal-title":"Eur J Pain"},{"key":"2026092513474583500_keag488-B15","doi-asserted-by":"crossref","first-page":"Jc34","DOI":"10.7326\/ACPJ202009150-034","article-title":"In knee OA, physical therapy reduced pain and improved function more than glucocorticoid injections at 1\u2009year","volume":"173","author":"Hunter","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026092513474583500_keag488-B16","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1056\/NEJMoa1905877","article-title":"Physical therapy versus glucocorticoid injection for osteoarthritis of the knee","volume":"382","author":"Deyle","year":"2020","journal-title":"N Engl J Med"},{"key":"2026092513474583500_keag488-B17","doi-asserted-by":"crossref","first-page":"e085242","DOI":"10.1136\/bmj-2025-085242","article-title":"Comparative efficacy and safety of exercise modalities in knee osteoarthritis: systematic review and network meta-analysis","volume":"391","author":"Yan","year":"2025","journal-title":"BMJ"},{"key":"2026092513474583500_keag488-B18","doi-asserted-by":"crossref","first-page":"n2321","DOI":"10.1136\/bmj.n2321","article-title":"Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis","volume":"375","author":"da Costa","year":"2021","journal-title":"BMJ"},{"key":"2026092513474583500_keag488-B19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jama.2020.22171","article-title":"Diagnosis and treatment of hip and knee osteoarthritis: a review","volume":"325","author":"Katz","year":"2021","journal-title":"JAMA"},{"key":"2026092513474583500_keag488-B20","first-page":"579","article-title":"Osteoarthritis. The role of physical and rehabilitation medicine physicians. The European perspective based on the best evidence. A paper by the UEMS-PRM Section Professional Practice Committee","volume":"49","author":"Ilieva","year":"2013","journal-title":"Eur J Phys Rehabil Med"},{"key":"2026092513474583500_keag488-B21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/jor.25706","article-title":"Topical nonsteroidal anti-inflammatory drug patches for osteoarthritis","volume":"42","author":"Muruganandam","year":"2024","journal-title":"J Orthop Res"},{"key":"2026092513474583500_keag488-B22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.joca.2022.11.008","article-title":"Sustained release of locally delivered celecoxib provides pain relief for osteoarthritis: a proof of concept in dog patients","volume":"31","author":"Tellegen","year":"2023","journal-title":"Osteoarthritis Cartilage"},{"key":"2026092513474583500_keag488-B23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ejps.2012.08.016","article-title":"Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe","volume":"47","author":"Komatsu","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"2026092513474583500_keag488-B24","first-page":"Cd007402","article-title":"Topical NSAIDs for acute musculoskeletal pain in adults","volume":"2015","author":"Derry","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026092513474583500_keag488-B25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/14397595.2016.1176624","article-title":"Efficacy of S-flurbiprofen plaster in knee osteoarthritis treatment: results from a phase III, randomized, active-controlled, adequate, and well-controlled trial","volume":"27","author":"Yataba","year":"2017","journal-title":"Mod Rheumatol"},{"key":"2026092513474583500_keag488-B26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/jphp.12914","article-title":"Analgesic effect of S (+)-flurbiprofen plaster in a rat model of knee arthritis: analysis of gait and synovial fluid prostaglandin E(2) levels","volume":"70","author":"Fukumoto","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"2026092513474583500_keag488-B27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.38271","article-title":"Involvement of peripheral and spinal tumor necrosis factor \u03b1 in spinal cord hyperexcitability during knee joint inflammation in rats","volume":"66","author":"K\u00f6nig","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026092513474583500_keag488-B28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/j.pain.0000000000001427","article-title":"Mechanistic pain profiling as a tool to predict the efficacy of 3-week nonsteroidal anti-inflammatory drugs plus paracetamol in patients with painful knee osteoarthritis","volume":"160","author":"Petersen","year":"2019","journal-title":"Pain"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keag488\/71010810\/keag488.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag488\/71010810\/keag488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/9\/keag488\/71010810\/keag488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:47:57Z","timestamp":1790358477000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keag488\/8789458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keag488","relation":{},"ISSN":["1462-0332"],"issn-type":[{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"keag488"}}